arrow
返回
K

Karl Turetschek

机构信息待补充

36H指数
112论文数
3.6K被引数
收录论文 22
发表时间
The choice of region of interest measures in contrast-enhanced magnetic resonance image characterization of experimental breast tumors
err2005-06-01
err32
PREAI
errPreda, A; Turetschek, K; Daldrup, H; Floyd, E; Novikov, V; Shames, DM; Roberts, TPL; Carter, WO; Brasch, RC
err分享
err收藏
MRI monitoring of avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer
err2004-10-22
err73
errOAAI
errPreda, A; Novikov, V; Möglich, M; Turetschek, K; Shames, DM; Brasch, RC; Cavagna, FM; Roberts, TPL
err分享
err收藏
Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weights
err2004-06-21
err114
PREAI
errTuretschek, K; Preda, A; Novikov, V; Brasch, RC; Weinmann, HJ; Wunderbaldinger, P; Roberts, TPL
err分享
err收藏
Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation
err2004-02-01
err57
PREAI
errSchulenburg, A; Turetschek, K; Wrba, F; Vogelsang, H; Greinix, HT; Keil, F; Mitterbauer, M; Kalhs, P
err分享
err收藏
Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: Initial phase II multicenter trial
errRADIOLOGY
IF15.2
err2003-12-01
err78
PREAI
errDaldrup-Link, HE; Rydland, J; Helbich, TH; Bjornerud, A; Turetschek, K; Kvistad, KA; Kaindl, E; Link, TM; Staudacher, K; Shames, D; Brasch, RC; Haraldseth, O; Rummeny, EJ
err分享
err收藏
MRI monitoring of tumor response following anglogenesis inhibition in an experimental human breast cancer model
err2003-03-01
err65
PREAI
errTuretschek, K; Preda, A; Floyd, E; Shames, DM; Novikov, V; Roberts, TPL; Wood, JM; Fu, YJ; Carter, WO; Brasch, RC
err分享
err收藏
MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model
err2002-02-01
err22
PREAI
errTuretschek, K; Preda, A; Floyd, E; Shames, DM; Novikov, V; Roberts, TPL; Wood, JM; Fu, YJ; Carter, WO; Brasch, RC
err分享
err收藏
Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights
err2002-02-01
err30
PREAI
errRoberts, TPL; Turetschek, K; Preda, A; Novikov, V; Moeglich, M; Shames, DM; Brasch, RC; Weinmann, HJ
err分享
err收藏
Noninvasive assessment of wound-healing angiogenesis with contrast-enhanced MRI
err2002-01-01
err18
PREAI
errHelbich, TH; Roberts, TPL; Rollins, MD; Shames, DM; Turetschek, K; Hopf, HW; Mühler, M; Hunt, TK; Brasch, RC
err分享
err收藏
Utility (or not) of Gd-DTPA-based dynamic MRI for breast cancer diagnosis and grading
err2002-01-01
err4
PREAI
errRoberts, TPL; Helbich, TH; Ley, S; Turetschek, K; Wendland, MF; Shames, DM; Brasch, RC
err分享
err收藏
err分享
err收藏
err分享
err收藏
MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation
errRADIOLOGY
IF15.2
err2001-02-01
err118
PREAI
errTuretschek, K; Huber, S; Floyd, E; Helbich, T; Roberts, TPL; Shames, DM; Tarlo, KS; Wendland, MF; Brasch, RC
err分享
err收藏
In vivo monitoring of tumor angiogenesis with MR imaging
err2000-10-01
err115
PREAI
errBrasch, RC; Li, KCP; Husband, JE; Keogan, MT; Neeman, M; Padhani, AR; Shames, D; Turetschek, K
err分享
err收藏
A new polysaccharide macromolecular contrast agent for MR imaging:: Biodistribution and imaging characteristics
err2000-01-01
err52
errOAAI
errHelbich, TH; Gossman, A; Mareski, PA; Radüchel, B; Roberts, TPL; Shames, DM; Mühler, M; Turetschek, K; Brasch, RC
err分享
err收藏
Comparison of low field (0.2T) and high field (1.5T) MR imaging in the differentiation of torned from intact menisci
err1999-04-01
err16
PREAI
errRand, T; Imhof, H; Turetschek, K; Schneider, B; Vögele, T; Gäbler, C; Trattnig, S
err分享
err收藏
Small bowel barium studies in Crohn's disease
err1998-06-01
err10
errOAAI
errGasche, C; Schober, E; Turetschek, K
err分享
err收藏